Houben Philipp, Bormann Eike, Kneifel Felicia, Katou Shadi, Morgül Mehmet Haluk, Vogel Thomas, Bahde Ralf, Radünz Sonia, Pascher Andreas, Schmidt Hartmut, Brockmann Jens Gunther, Becker Felix
Department of General, Visceral and Transplant Surgery, University Hospital Münster, 48149 Münster, Germany.
Institute of Biostatistics and Clinical Research, University Hospital Münster, 48149 Münster, Germany.
J Clin Med. 2022 Jul 4;11(13):3899. doi: 10.3390/jcm11133899.
In liver transplantation, older donor age is a well-known risk factor for dismal outcomes, especially due to the high susceptibility of older grafts to ischemia-reperfusion injury. However, whether the factors correlating with impaired graft and patient survival following the transplantation of older grafts follow a linear trend among elderly donors remains elusive. In this study, liver transplantations between January 2006 and May 2018 were analyzed retrospectively. Ninety-two recipients of grafts from donors ≥65 years were identified and divided into two groups: (1) ≥65-69 and (2) ≥ 70 years. One-year patient survival was comparable between recipients of grafts from donors ≥65-69 and ≥70 years (78.9% and 70.0%). One-year graft survival was 73.1% (donor ≥65-69) and 62.5% (donor ≥ 70), while multivariate analysis revealed superior one-year graft survival to be associated with a donor age of ≥65-69. No statistically significant differences were found for rates of primary non-function. The influence of donor age on graft and patient survival appears not to have a distinct impact on dismal outcomes in the range of 65-70 years. The impact of old donor age needs to be balanced with other risk factors, as these donors provide grafts that offer a lifesaving graft function.
在肝移植中,供体年龄较大是预后不良的一个众所周知的风险因素,特别是因为老年移植物对缺血再灌注损伤的高度易感性。然而,在老年供体中,与老年移植物移植后移植物和患者生存受损相关的因素是否呈线性趋势仍不清楚。在本研究中,对2006年1月至2018年5月期间的肝移植进行了回顾性分析。确定了92名接受≥65岁供体移植物的受者,并将其分为两组:(1)≥65 - 69岁和(2)≥70岁。接受≥65 - 69岁和≥70岁供体移植物的受者的1年患者生存率相当(分别为78.9%和70.0%)。1年移植物生存率分别为73.1%(供体≥6